Rwanda: How Can Rwandans Acquire New HIV Preventive Drug At a Lower Price?

Rwanda: How Can Rwandans Acquire New HIV Preventive Drug At a Lower Price?

Rwanda is among the countries interested in Lenacapavir, a newly approved, long-acting preventive injection, though its cost is seemingly out of reach for many developing countries.

Rwanda to Roll Out New HIV Prevention Injection by 2026

PDF Button Rwanda is expected to begin offering a new long-acting HIV prevention drug, Lenacapavir Yeztugo, by 2026, according to the Rwanda Biomedical Center (RBC). Dr. Basile Ikuzo, Director of HIV Prevention Unit at RBC, said the drug which is administered only twice a year could help ease the burden on high-risk groups who currently […] Related Posts: Water-saving irrigation boosts land productivity in Rwanda Rwanda employs innovative solu…